Advancing the Next Generation of iPSC-derived NK Cell and Macrophage Immunotherapies Leading the Legacy of the Most Effective and Affordable Cell Therapies We develop genetically engineered induced pluripotent stem cell (iPSC)-derived allogeneic natural killer (NK) and macrophage products that are intelligently designed for greater potency and persistence, overcoming the limitations of early cell therapies, for […]
Location: United States, California, San Diego
Employees: 51-200
Total raised: $43M
Founded date: 2020
Investors 2
| Date | Name | Website |
| 21.02.2021 | Logos Capi... | logoscapit... |
| - | Timefolio ... | timefolioc... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.04.2021 | - | $43M | - |
Mentions in press and media 10
| Date | Title | Description | Source |
| 02.11.2021 | Shoreline Biosciences Announces $140M Financing To Advance P... | Financing accelerates the growth of Shoreline’s pipeline of iPSC-based cell immunotherapies for the ... | ally-bridg... |
| 02.11.2021 | Why American Eagle’s $350 million deal matters | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 02.11.2021 | Why American Eagle’s $350 million deal matters | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 02.11.2021 | Shoreline Biosciences Raises $140M | SAN DIEGO, CA, Shoreline Biosciences today announced the completion of a $140 million financing. ... | vcnewsdail... |
| 02.11.2021 | Shoreline Biosciences Announces $140M Financing To Advance P... | SAN DIEGO, Nov. 2, 2021 /PRNewswire/ -- Shoreline Biosciences, Inc. (Shoreline), a biotechnology com... | marketscre... |
| 08.04.2021 | Shoreline Biosciences Raises $43M in Financing | Shoreline Biosciences, Inc., a San Diego, CA-based biotechnology company, completed a $43M funding r... | finsmes.co... |
| 08.04.2021 | Shoreline Biosciences has raised a $43M round to accelerate ... | - | connect.or... |
| 07.04.2021 | Shoreline Biosciences Announces $43M Financing To Advance Pi... | SAN DIEGO, April 7, 2021 /PRNewswire/ -- Shoreline Biosciences, Inc. (Shoreline), a biotechnology co... | marketscre... |
| 07.04.2021 | Shoreline Biosciences Announces $43M Financing To Advance Pi... | SAN DIEGO, April 7, 2021 /PRNewswire/ -- Shoreline Biosciences, Inc. (Shoreline), a biotechnology ... | prnewswire... |
| - | Shoreline Biosciences secures $140M for off-the-shelf NK cel... | Shoreline Biosciences’ work developing “off-the-shelf” cell therapies for cancer has led to strategi... | medcitynew... |